相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21
Keishi Fukuura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence
Giulia Santinon et al.
EMBO JOURNAL (2018)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
Mai Nagasaka et al.
MOLECULES (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
p53 shades of Hippo
Noa Furth et al.
CELL DEATH AND DIFFERENTIATION (2018)
p53 on the crossroad between regeneration and cancer
Meital Charni et al.
CELL DEATH AND DIFFERENTIATION (2017)
The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress
Yasumichi Inoue et al.
FEBS LETTERS (2017)
Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
Zubing Mei et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
M. Escoll et al.
ONCOGENE (2017)
Transcriptional coactivator with PDZ-binding motif is required to sustain testicular function on aging
Mi Gyeong Jeong et al.
AGING CELL (2017)
Negative regulation of the p300-p53 interplay by DDX24
D. Shi et al.
ONCOGENE (2016)
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
Yuki Kawarada et al.
SCIENTIFIC REPORTS (2016)
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Xiao Zhen Zhou et al.
NATURE REVIEWS CANCER (2016)
Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation
Chiharu Miyajima et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Statins are potential anticancerous agents (Review)
Abdullah K. Altwairgi
ONCOLOGY REPORTS (2015)
Senescence and apoptosis: dueling or complementary cell fates?
Bennett G. Childs et al.
EMBO REPORTS (2014)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Aging, Cellular Senescence, and Cancer
Judith Campisi
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1
Yasumichi Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation
Oleg Laptenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The impact of acetylation and deacetylation on the p53 pathway
Christopher L. Brooks et al.
PROTEIN & CELL (2011)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq-Chainiaux et al.
NATURE PROTOCOLS (2009)
ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
Qiuyan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Bin Zhao et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage
Yasumichi Inoue et al.
EMBO JOURNAL (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Regulating the p53 pathway:: in vitro hypotheses, in vivo veritas
Franck Toledo et al.
NATURE REVIEWS CANCER (2006)
Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65
EM Morin-Kensicki et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Regulation of HDM2 activity by the ribosomal protein L11
MAE Lohrum et al.
CANCER CELL (2003)
Decision making by p53: life, death and cancer
M Oren
CELL DEATH AND DIFFERENTIATION (2003)
MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation
A Ito et al.
EMBO JOURNAL (2002)
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins
F Kanai et al.
EMBO JOURNAL (2000)
分享论文
